167 related articles for article (PubMed ID: 2831187)
1. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.
Lalazar A; Weisgraber KH; Rall SC; Giladi H; Innerarity TL; Levanon AZ; Boyles JK; Amit B; Gorecki M; Mahley RW
J Biol Chem; 1988 Mar; 263(8):3542-5. PubMed ID: 2831187
[TBL] [Abstract][Full Text] [Related]
2. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
Horie Y; Fazio S; Westerlund JR; Weisgraber KH; Rall SC
J Biol Chem; 1992 Jan; 267(3):1962-8. PubMed ID: 1730728
[TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein E. Receptor binding activity of truncated variants with carboxyl-terminal deletions.
Lalazar A; Mahley RW
J Biol Chem; 1989 May; 264(15):8447-50. PubMed ID: 2542277
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of two monoclonal antibodies specific for the LDL receptor-binding site of human apolipoprotein E.
Raffai R; Maurice R; Weisgraber K; Innerarity T; Wang X; MacKenzie R; Hirama T; Watson D; Rassart E; Milne R
J Lipid Res; 1995 Sep; 36(9):1905-18. PubMed ID: 8558079
[TBL] [Abstract][Full Text] [Related]
5. Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor.
Morrow JA; Arnold KS; Dong J; Balestra ME; Innerarity TL; Weisgraber KH
J Biol Chem; 2000 Jan; 275(4):2576-80. PubMed ID: 10644716
[TBL] [Abstract][Full Text] [Related]
6. The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity.
Dong LM; Innerarity TL; Arnold KS; Newhouse YM; Weisgraber KH
J Lipid Res; 1998 Jun; 39(6):1173-80. PubMed ID: 9643348
[TBL] [Abstract][Full Text] [Related]
7. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
Ji ZS; Fazio S; Mahley RW
J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
[TBL] [Abstract][Full Text] [Related]
8. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.
Hoffmann MM; Scharnagl H; Panagiotou E; Banghard WT; Wieland H; März W
J Am Soc Nephrol; 2001 Mar; 12(3):524-530. PubMed ID: 11181800
[TBL] [Abstract][Full Text] [Related]
9. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.
Dong LM; Wilson C; Wardell MR; Simmons T; Mahley RW; Weisgraber KH; Agard DA
J Biol Chem; 1994 Sep; 269(35):22358-65. PubMed ID: 8071364
[TBL] [Abstract][Full Text] [Related]
10. Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity.
Wardell MR; Rall SC; Schaefer EJ; Kane JP; Weisgraber KH
J Lipid Res; 1991 Mar; 32(3):521-8. PubMed ID: 1648586
[TBL] [Abstract][Full Text] [Related]
11. The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity.
Pham T; Kodvawala A; Hui DY
Biochemistry; 2005 May; 44(20):7577-82. PubMed ID: 15896001
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E isoforms and lipoprotein metabolism.
Phillips MC
IUBMB Life; 2014 Sep; 66(9):616-23. PubMed ID: 25328986
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand.
Zaiou M; Arnold KS; Newhouse YM; Innerarity TL; Weisgraber KH; Segall ML; Phillips MC; Lund-Katz S
J Lipid Res; 2000 Jul; 41(7):1087-95. PubMed ID: 10884290
[TBL] [Abstract][Full Text] [Related]
14. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces.
Futamura M; Dhanasekaran P; Handa T; Phillips MC; Lund-Katz S; Saito H
J Biol Chem; 2005 Feb; 280(7):5414-22. PubMed ID: 15583000
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127.
Wardell MR; Weisgraber KH; Havekes LM; Rall SC
J Biol Chem; 1989 Dec; 264(35):21205-10. PubMed ID: 2556398
[TBL] [Abstract][Full Text] [Related]
16. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
Ji ZS; Fazio S; Lee YL; Mahley RW
J Biol Chem; 1994 Jan; 269(4):2764-72. PubMed ID: 8300609
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.
Morrow JA; Arnold KS; Weisgraber KH
Protein Expr Purif; 1999 Jul; 16(2):224-30. PubMed ID: 10419818
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
[TBL] [Abstract][Full Text] [Related]
19. Receptor-ligand interaction between vitellogenin receptor (VtgR) and vitellogenin (Vtg), implications on low density lipoprotein receptor and apolipoprotein B/E. The first three ligand-binding repeats of VtgR interact with the amino-terminal region of Vtg.
Li A; Sadasivam M; Ding JL
J Biol Chem; 2003 Jan; 278(5):2799-806. PubMed ID: 12429745
[TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.
Vogel T; Weisgraber KH; Zeevi MI; Ben-Artzi H; Levanon AZ; Rall SC; Innerarity TL; Hui DY; Taylor JM; Kanner D
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8696-700. PubMed ID: 3909150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
